Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Home > ½ÃÀ庸°í¼­ > ¸ÞµðÄõð¹ÙÀ̽º > ºÐÀÚ¿µ»ó/Á¶¿µÁ¦ > ÀÇ·á¿ë È­»ó ÀåÄ¡ ½ÃÀå Vol.4£ºÁ¶¿µÁ¦
Ä«Å×°í¸®
¸ÞµðÄõð¹ÙÀ̽º (4154)
³»½Ã°æ (116)
ºÐÀÚ¿µ»ó/Á¶¿µÁ¦ (29)
½ÉÇ÷°üÀåÄ¡ (250)
¾È°ú±â±â (100)
ÀÇ·á¿ë ¿µ»óÁø´ÜÀåÄ¡ (404)
ÀÇ·á¿ë ÀÏȸ¿ëǰ (84)
Á¤Çü¿Ü°ú (338)
â»ó°ü¸® (127)
ü¿ÜÁø´ÜÀåÄ¡(IVD) (444)
ÃÊÀ½ÆÄ (49)
Ä¡°ú±â±â (174)
Ä«Å×ÅÍ (205)
ÇÙÀÇ·á (71)
ÇコÄɾî IT (307)
ȯÀÚ¸ð´ÏÅ͸µ (385)
CT/MRI/X-ray (145)
½ÃÀ庸°í¼­

ÀÇ·á¿ë È­»ó ÀåÄ¡ ½ÃÀå Vol.4£ºÁ¶¿µÁ¦

Medical Imaging Markets, Volume IV: Contrast Agents

¸®¼­Ä¡»ç Kalorama Information
¹ßÇàÀÏ 2007³â 02¿ù »óǰÄÚµå 49644
ÆäÀÌÁö Á¤º¸ 124 pages
°¡°Ý
US $ 1,995 £Ü 2,264,900 PDF by E-mail (Single User License)
US $ 3,395 £Ü 3,854,300 PDF by E-mail (Single User License) & Hard Copy
US $ 3,395 £Ü 3,854,300 Hard Copy
US $ 5,990 £Ü 6,800,400 PDF by E-mail (Global Site License)


Kalorama Information ¿¡¼­ 2007³â 02¿ù ¿¡ ¹ßÇàÇÑ ¡¸ÀÇ·á¿ë È­»ó ÀåÄ¡ ½ÃÀå Vol.4£ºÁ¶¿µÁ¦¡¹ º¸°í¼­´Â 124 pages·Î ±¸¼ºµÇ¾î, US $1,995 ºÎÅÍ ±¸¸Å °¡´ÉÇÕ´Ï´Ù.

Çѱ۸ñÂ÷

ÇöÀç, ±âÁ¸ÀÇ ¸ð´Þ¸®Æ¼¸¦ »õ·Î¿î ¹æ½ÄÀ¸·Î ÀÌ¿ëÇϱâ À§ÇØ ´Ù¾çÇÑ Á¶¿µÁ¦°¡ °³¹ßµÇ°í ÀÖ½À´Ï´Ù. ±× Áß¿¡´Â ±âÁ¸ÀÇ Á¶¿µÁ¦¿Í °æÀïÇÏ´Â °Íµµ ÀÖ°í, »õ·Î¿î ½ÃÀåÀ» Ž»öÇÏ¿© ÀÌÁ¦±îÁö ¾ø´ø Áø´ÜÀ» °¡´ÉÄÉ ÇÏ´Â °Íµµ ÀÖ½À´Ï´Ù.

Á¦¾à, ¹ÙÀÌ¿À, ÀÇ·á ±â±â¸¦ ºñ·ÔÇÑ ´Ù¾çÇÑ ¶óÀÌÇÁ»çÀ̾𽺠½ÃÀå¿¡ ´ëÇÑ Á¶»ç¸¦ Àü¹®À¸·Î ÇÏ´Â Á¶»çȸ»ç Kalorama Information£¨º»»ç£º´º¿åÁÖ£©¿¡¼­´Â Á¶¿µÁ¦ ½ÃÀå¿¡ ´ëÇÑ Á¶»ç ºÐ¼® º¸°í¼­ ¡°Medical Imaging Markets, Volume IV: Contrast Agents¡±¸¦ ¹ßÇàÇß½À´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­´Â Àü¼¼°èÀÇ Á¶¿µÁ¦ ½ÃÀå ÇöȲ°ú 2010³â±îÁöÀÇ ¸ð´Þ¸®Æ¼º° ¼öÀÍ ¿¹Ãø, ÁÖ¿äÇÑ Á¶¿µÁ¦ °ø±Þ¾÷üÀÇ ½ÃÀå Á¡À¯À², ±â¼ú °³¹ß µ¿Çâ, °³¹ßÁßÀÎ ½ÅÁ¦Ç° µ¿Ç⠵ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

    1. ÁÖ¿ä ¿ä¾à
    • Á¶¿µÁ¦ÀÇ ¿ªÇÒ
    • ¸ð´Þ¸®Æ¼ÀÇ »ç¿ë
    • ¼¼°è ½ÃÀå °³¿ä
    • ¹æ¹ý·Ð
    2. ¼­·Ð
    • °³¿ä
    • Àü¸Á
    • ÁÖ¿äÇÑ Á¶¿µÁ¦ ½ÃÀå
      • ¹æ»ç¼±£¨X¼±£©¹× CT
      • ÃÊÀ½ÆÄ
      • MRI
      • ÇÙ ÀÇÇÐ
      • PET
      • SPECT
      • °¨¸¶Ä«¸Þ¶ó
    • À̿¼º/ºñÀ̿¼º Á¶¿µÁ¦
    • ¹®Á¦¿Í °úÁ¦
    3. À¯¸ÁÇÑ °³¹ß µ¿Çâ
    • Ãæ¼ö¿°À» À§ÇÑ ¹æ»ç¼± È­»ó
    • ¾ËÃ÷ÇÏÀ̸Ӻ´À» À§ÇÑ PET
    • Á¶¿µÁ¦°¡ ÃËÁøÇÏ´Â MRI ¸¾¸ð±×·¥(À¯¹æ ÃÔ¿µ)
    • Á¶¿µÁ¦¿Í MRIÀÇ °áÇÕ ½Ã½ºÅÛ
    • Á¶¿µÁ¦¿¡ ÀÇÇÑ Ç÷°ü Á¶¿µ
    • ´Ù¼öÀÇ MRI ȸÇÇ(Avoiding Multiple MRIs)
    • È­ÇÐ ½ÃÇÁÆ® È­»ó óġ(Chemical Shift Imaging)
    • Perfusion CT
    • ¸ÖƼ ¸ð´Þ Á¶¿µ¹ý(Multimodal Contrast)
    4. ½ÃÀå
    • ½ÃÀå ÃËÁø ÀÎÀÚ
    • óġ ¹× »óȯ
    • Á¶¿µÁ¦ ½ÃÀå ±Ô¸ð ¹× ÇâÈÄ Àü¸Á
    • ºÐÀÚ Á¶¿µÁ¦ ½ÃÀå ±Ô¸ð ¹× ÇâÈÄ Àü¸Á
    • °æÀï µ¿Çâ
    5. ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Acusphere Inc.
    • Advanced Magnetics Inc.
    • ART Advanced Research Technologies Inc.
    • Bristol-Myers Squibb
    • Boston Life Sciences
    • Bracco SpA
    • Cell Point
    • Cytogen Corp.
    • Daiichi Pharmaceutical Co. Ltd.
    • Dendritic NanoTechnologies Inc.
    • Dowpharma
    • Draximage
    • Epix Pharmaceuticals Inc.
    • E-Z-EM Inc.
    • GE Healthcare
    • Guerbet Group
    • Hovione FarmaCiencia SA
    • Imcor Pharmaceutical Co.
    • Immunomedics Inc.
    • King Pharmaceuticals Inc.
    • Luna nanoWorks
    • Macrocyclics
    • Mallinckrodt
    • Palatin Technologies Inc.
    • Pharmacyclics
    • Point Biomedical Corp.
    • Schering AG
    6. µµÇ¥
shiduck
Back to Top